Modified tunicamycins with reduced eukaryotic toxicity that enhance the antibacterial activity of β-lactamsNeil P. J. Price, Kenneth M. Bischoff, Todd A. Naumann et al.|The Journal of Antibiotics|2017Cited by 32
Targeting hyperactive TGFBR2 for treating MYOCD deficient lung cancerQian Zhou, Liang Chen, Wensheng Chen et al.|Theranostics|2021Cited by 30